Fundz

Stramsen Biotech, Inc Announces $10 Million Series Financing Round At $807 Million Valuation

PRIVATEOct 20, 2023

Amount Raised

$10 Million

Round Type

Series F

HoustonBiotechnology

Description

Three years from establishment Stramsen Biotech, Inc, one of the leading plant-based biotech start-up companies, is raising $10 million at a $807 million valuation according to a third-party valuation company based in Los Angeles, California - Stonebridge Advisory. Stramsen Biotech team believes that other valuation methods or models may show the company's value at around $5 billion. Currently officially valued at $807 million, Stramsen Biotech is now one of the world's largest Biotech Start-ups based on the company's pipeline.

Quick answer

Stramsen BiotechInc raised $10 Million in a Series F round, dated October 20, 2023. Stramsen BiotechInc is based in Houston, Texas, United States.

How much did Stramsen BiotechInc raise?
Stramsen BiotechInc raised $10 Million in a Series F round on October 20, 2023.
What does Stramsen BiotechInc do?
Stramsen Biotech Inc. is a Texas-based biopharmaceutical company that uses natural plant based approach to develop medicines that will transform the lives of many patients.
Where is Stramsen BiotechInc based and how big is it?
Stramsen BiotechInc is based in Houston, Texas, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Stramsen BiotechInc that raised within 45 days of this round, from Fundz verified event records.

  • DasiSimulations raised $2.8M (Seed) on December 4, 2023.
  • Proteocyte Diagnostics raised $37K (Pre-Seed) on December 4, 2023.
  • Seismic Therapeutic raised $121M (Series B) on December 4, 2023.
  • Cellanome, Inc raised $150M on December 4, 2023.
  • Perpetual Medicines raised $8M (Seed) on December 1, 2023.
  • Apothewell raised $11K (Pre-Seed) on December 1, 2023.

Who to call at Stramsen BiotechInc, and when

A new round usually means Stramsen BiotechInc is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Stramsen BiotechInc raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Stramsen BiotechInc, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Stramsen BiotechInc. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Stramsen BiotechInc

Location

Houston, Texas, United States

About

Stramsen Biotech Inc. is a Texas-based biopharmaceutical company that uses natural plant based approach to develop medicines that will transform the lives of many patients. We have over 8,000 medicinal plants database accessible to our scientists. We are heavily focused on developing Medicines for infectious and noninfectious diseases. Stramsen Biotech Inc was incorporated in Delaware in November 2020 and we are based in Houston, Texas. Stramsen Biotech Inc is a clinical-stage Biotechnology company that focuses on the development of innovative therapeutics for the treatment of different kinds of infectious and noninfectious diseases. The List of diseases includes Cancer, Covid-19, HIV and Cuts and Wounds.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Stramsen BiotechInc raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Stramsen BiotechInc's next move

See what Strategic adds

Stramsen BiotechInc raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.